PLIANT THERAPEUTICS, INC.
For the period ended Dec 31, 2025. Filed Mar 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
Item 15. Exhibits, Financial Statement Schedules.
(a)The following documents are filed as part of this Annual Report:
Financial Statements. See Index to Financial Statements in Part II Item 8 of this Annual Report on Form 10-K.
Financial Statement Schedules. None. All financial statement schedules are omitted because they are not applicable, not required under the instructions, or the requested information is included in the financial statements or notes thereto.
Exhibits. The following is a list of exhibits filed with this Annual Report or incorporated herein by reference:
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | FileHerewith |
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect. | 10-Q | 001-39303 | 3.1 | August 11, 2020 | |
| 3.2 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect. | 8-K | 001-39303 | 3.1 | June 9, 2025 | |
| 3.3 | Third Amended and Restated Bylaws of the Registrant, as currently in effect. | 8-K | 001-39303 | 3.1 | September 27, 2024 | |
| 3.4 | Certificate of Designation of Series A Junior Participating Preferred Stock | 8-K | 001-39303 | 3.1 | March 13, 2025 | |
| 4.1 | Specimen Common Stock Certificate of the Registrant. | S-1/A | 333-238146 | 4.1 | May 26, 2020 | |
| 4.2 | Description of the Registrant’s Securities | X | ||||
| 4.3 | Stockholder Rights Agreement, dated as of March 12, 2025, by and between the Company and Computershare Trust Company, N.A., as rights agent (which includes the Form of Rights Certificate as Exhibit B thereto) | 8-A | 001-39303 | 4.1 | March 13, 2025 | |
| 4.4 | Amendment to Stockholder Rights Agreement, dated as of March 3, 2026, by and between the Company and Computershare Trust Company, N.A., as rights agent | 8-K | 001-39303 | 4.2 | March 3, 2026 | |
| 10.1# | 2020 Stock Option and Incentive Plan and forms of award agreement. | S-1/A | 333-238146 | 10.2 | May 26, 2020 | |
| 10.2# | 2015 Equity Incentive Plan and forms of award agreements thereunder. | S-1 | 333-238146 | 10.1 | May 11, 2020 | |
| 10.3# | 2020 Employee Stock Purchase Plan. | S-1/A | 333-238146 | 10.3 | May 26, 2020 | |
| 10.4# | Senior Executive Cash Incentive Bonus Plan. | S-1 | 333-238146 | 10.4 | May 11, 2020 | |
| 10.5# | Executive Severance Plan. | S-1 | 333-238146 | 10.7 | May 11, 2020 | |
| 10.6# | Offer Letter, by and between the Registrant and Keith Cummings, M.D., MBA, dated November 29, 2018. | S-1 | 333-238146 | 10.10 | May 11, 2020 | |
| 10.7# | Offer Letter, by and between the Registrant and Bernard Coulie, M.D., Ph.D., dated October 12, 2015. | S-1 | 333-238146 | 10.8 | May 11, 2020 | |
| 10.8# | Offer Letter, by and between the Registrant and Lily Cheung, dated December 21, 2022. | 10-K | 001-39303 | 10.21 | March 9, 2023 | |
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | FileHerewith |
| 10.9# · Offer Letter, by and between the Registrant and Minnie Kuo, dated August 23, 2023 · X | ||||||
| 10.10# · Separation Agreement and General Release of Claims, by and between the Registrant and Eric Lefebvre, effective January 9, 2026. · X | ||||||
| 10.11# · Consulting Agreement, by and between the Registrant and Eric Lefebvre, dated December 16, 2025 · X | ||||||
| 10.12# | Form of Indemnification Agreement, by and between the Registrant and each of its directors and certain officers. | S-1 | 333-238146 | 10.13 | May 11, 2020 | |
| 10.13# | 2022 Inducement Plan dated September 14, 2022. | 10-K | 001-39303 | 10.14 | March 3, 2025 | |
| 10.14# | Lease Agreement by and between the Registrant and HCP BTC, LLC, dated September 28, 2023. | 8-K | 001-39303 | 10.1 | October 23, 2023 | |
| 10.15# | Amended and Restated Non-Employee Director Compensation Policy | 10-Q | 001-39303 | 10.1 | May 8, 2025 | |
| 10.16# | Form of Retention Agreement | 10-Q | 001-39303 | 10.1 | August 7, 2025 | |
| 19.1 | Insider Trading Policy | X | ||||
| 23.1 | Consent of Independent Registered Public Accounting Firm | X | ||||
| 31.1 | Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2 | Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1** | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 97 | Clawback Policy | 10-K | 001-39303 | 97 | February 27, 2024 | |
| 101.INS | Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Document | X | ||||
| 101.LAB | Inline XBRL Taxonomy Label Linkbase Document | X | ||||
| Incorporated by Reference | ||||||
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | FileHerewith |
| 101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document | X | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | X | ||||
** The certifications furnished in Exhibit 32.1 hereto are deemed to be furnished with this Annual Report on Form 10-K and will not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates them by reference
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.